Time filter

Source Type

Dalmacio Vélez Sársfield, Argentina

We present a retrospective and multicentric study to evaluate the measurement of preablation Thyroglobulin (Tg) as a predictor of the evolution of 274 patients with DTC. All the patients included in the study had negative TgAb, were treated with total thyroidectomy, ablation of the remnant tissue and an evolution period of more than 2 years. We measured preablation Tg under stimulation with endogenous TSH. We correlated the preablation Tg with that at the first control at LT4 withdrawal, with TNM stratification and the final statement of the disease at Final Time (FT). At the end of the evolution period, patients were classified as: free of disease (n=172), with doubtful disease (n=43) and with persistent disease (n=50). According to their Tg levels, patients were subdivided the following ranges of Tg: 0.5-2.0; 2.1-10.0; 10.1-40.0; 40.1-100 and >100 ng/mL. There was not significant correlation between preablation Tg and TNM stratification. We observed correlation between preablation Tg and the first stimulated Tg ≤2.0 ng/mL as 86.7 % of the patients persisted in this range while the rest of them either moved to a lower or a higher range in response to the ablation. Considering the relationship between preablation Tg and the state of disease at FT, we found out that most of the patients with preablation Tg <10.0 ng/mL were free of disease. TNM classification correlated with the final state of the disease, with low risk patients having a high probability of being free of disease. In patients with CDT, preablation Tg below ≤10.0 ng/mL could be a marker of good prognosis. We consider that preablation Tg can be a valuable tool to predict the evolution and risk of patients with CDT. Copyright © 2011 por la Sociedad Argentina de Endocrinología y Metabolismo. Source

Discover hidden collaborations